NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-095-2000-0-EP-06 IDENTIFICATION OF A NOVEL DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION. EP National Stage 01910476.9 Abandoned
NIAID E-095-2000-0-AU-04 IDENTIFICATION OF A NOVEL DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION. AU National Stage 2001238076 Abandoned
NIAID E-095-2000-0-CA-05 IDENTIFICATION OF A DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION. CA National Stage 2399388 Abandoned
NIA E-251-1997-0-US-07 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof US National Stage 09/762,538 7056734 Abandoned PDF
NICHD E-147-1996-4-US-01 Prenatal Treatment With ADNF Polypeptides to Improve Learning and Memory US 60/267,805 Abandoned
NINDS E-286-1999-0-PCT-02 Constituitively Open Voltage-Gated K+Channels And Methods For Discovering Modulators Thereof PCT PCT PCT/US01/03963 Expired
NINDS E-278-2000-1-US-01 Differentiaton of Embryonic Stem Cells to Pancreatic Endocrine Cells US 60/266,917 Abandoned
NCI E-276-2000-0-US-01 Method of Inhibiting Viral Replication Targeting The Nucleocapsid Protein US 60/266,665 Abandoned
NIMH E-287-1997-2-US-06 CANNABINOIDS AS ANTIOXIDANTS AND NEUROPROTECTANTS US National Stage 09/674,028 6630507 Expired PDF
NIAID E-188-1992-0-US-07 T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME US CON 09/776,520 Abandoned
NIAID E-188-1992-0-US-08 T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME US CON 09/776,522 Abandoned
NHLBI E-204-1998-0-US-03 Methods and Compostitions for HDL Holoparticle Uptake Receptor US National Stage 09/700,455 6846636 Abandoned PDF
NCI E-072-2001-0-US-01 Identification of New Small RNAs and ORFs US 60/266,402 Abandoned
NCI E-070-2001-0-AU-01 Chemical Compounds And Methods AU ORD 2001PR2838 Expired
NIDCR E-312-2000-0-US-01 Hybrid Adenoviral Vector US 60/265,198 Abandoned
NCI E-026-2001-0-US-03 Cosalane Compounds And Methods For Their Use6182017 US CON 09/771,769 6562805 Abandoned PDF
NIDCR E-131-1998-0-US-35 Thymosin B4 Promotes Wound Repair US DIV 12/938,228 Expired
NIDCR E-131-1998-0-US-08 Thymosin Beta4 Promotes Wound Repair US CON 09/772,445 Expired
NCI E-090-2000-1-EP-10 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 EP DIV 10010354.8 Expired
NIAID E-088-2000-0-CA-05 COMPOSITIONS AND METHOD FOR PREVENTING REACTOGENICITY ASSOCIATED WITH ADMINISTRATION OF IMMUNOGENIC LIVE ROTAVIRUS COMPOSITIONS CA National Stage 2398428 Expired
NCI E-090-2000-1-CA-02 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 CA National Stage 2398743 Expired
NCI E-090-2000-1-JP-05 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 JP National Stage 2001-554422 Abandoned
NIAID E-088-2000-0-GB-10 Compositions And Method For Preventing Reactogenicity Associated With Administration of Immunogenic Live Rotavirus Composition GB EP 01905127.5 Expired
NIAID E-088-2000-0-DE-08 Compositions And Method For Preventing Reactogenicity Associated With Administration of Immunogenic Live Rotavirus Composition DE EP 01905127.5 Expired
NIAID E-088-2000-0-FR-09 Compositions And Method For Preventing Reactogenicity Associated With Administration of Immunogenic Live Rotavirus Composition FR EP 01905127.5 Expired
NIAID E-088-2000-0-EP-07 Compositions And Method For Preventing Reactogenicity Associated With Administration of Immunogenic Live Rotavirus Composition EP National Stage 01905127.5 Expired
NCI E-090-2000-1-AU-03 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 AU National Stage 2001033062 Expired
NIAID E-088-2000-0-AU-04 Compositions and Method For Preventing Reactogenicity Associated With Administration Of Immunogenic Live Rotavirus Compositions AU National Stage 2001033040 Expired
NCI E-090-2000-1-PCT-01 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 PCT PCT COMB PCT/US2001/002765 Expired
NIAID E-088-2000-0-PCT-02 Compositions And Method For Preventing Reactogenicity Associated With Administration of Immunogenic Live Rotavirus Composition PCT PCT PCT/US2001/002686 Expired
NIAID E-171-1986-1-US-05 Pertussin Toxin Gene: Cloning and Expression of Protective Antigen US CON 09/770,875 Abandoned
NCI E-090-2000-1-EP-09 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 EP DIV 10010389.4 Abandoned
NCI E-090-2000-1-EP-08 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 EP DIV 10010353.0 Abandoned
NCI E-090-2000-1-EP-04 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 EP National Stage 01905152.3 Abandoned
NCI E-290-2000-0-US-01 Detection And Quantification of Cripto-1 US 60/264,643 Abandoned
NCI E-099-1989-0-US-06 Antibodies for The Alpha Platelet-Derived Growth Factor Receptor US DIV 09/769,987 6660488 Expired PDF
NCI E-062-2000-2-PCT-01 A Novel Pro-Apoptotic Protein, ARTS PCT PCT COMB PCT/US01/02466 Expired
NIDA E-057-2000-0-PCT-02 TREATMENT OF Neuropsychiatric Disease With Protease And Neuraminidase Inhibitors PCT PCT PCT/US01/02417 Abandoned
NCI E-116-2001-0-US-01 Formulation of Boronic Acid Compounds US 60/264,160 Abandoned
NIAID E-068-1998-0-US-03 INTERFERON ALPHA HYBRIDS (as filed) US National Stage 09/744,754 6685933 Expired PDF
NHGRI E-051-2000-2-PCT-01 Amplified Genes at 17q23 PCT PCT COMB PCT/US01/02474 Abandoned
NCI E-054-1994-0-US-04 Method of Inducing Cell-Mediated Protective Immunity Against HIV Using Low Doses of Immunogens US CON 09/769,223 Abandoned
NCI E-188-2000-0-US-01 Method of Preparing a Production Intermediate For HIV Protease Inhibitors US 60/264,165 Abandoned
NINDS E-278-2000-0-US-01 Differentiation of stem Cells to Pancreatic Endocrine Cells US 60/264,107 Abandoned
NCI E-091-2007-1-US-05 Variant of LAV viruses US CON 09/767,138 7029679 Expired PDF
NIEHS E-333-2001-0-US-01 A Test for Linkage and Association in General Pedigress: The Pedigree Disequilibrium Test (PDT) US ORD 09/767,453 6697739 Abandoned PDF
NIDDK E-227-1995-0-US-03 RNase L Activators and Antisense Oligonucleotides Effective to Treat RSV Infections US CON 09/767,484 Abandoned
NCI E-095-2002-0-US-02 Nucleic Acids of the Human ABCA5, ABCA6, ABCA9 and ABCA10 Genes, Vectors Containing Such Nucleic Acids and Uses Thereof US 60/263,231 Abandoned
NCI E-258-1999-0-US-02 Inhibition of MXR Transport By Acridine Derivatives US ORD 09/767,594 6521635 Expired PDF
NCI E-128-1998-1-US-02 USE OF CONSTITUTIVE TRANSPORT ELEMENTS FOR HOST RANGE CONTROL US National Stage 09/744,022 6492166 Expired PDF